Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms

被引:669
作者
Li, Ming O.
Sanjabi, Shomyseh
Flavell, Richard A. [1 ]
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
关键词
D O I
10.1016/j.immuni.2006.07.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of transforming growth factor-beta (TGF-beta) in inhibiting T cell functions has been studied with dominant-negative TGF-beta receptor transgenic models; however, the full impact of TGF-beta signaling on T cells and the mechanisms by which TGF-beta signals remain poorly understood. Here we show that mice with T cell-specific deletion of TGF-beta receptor II developed lethal inflammation associated with T cell activation and differentiation. In addition, TGF-beta signaling positively regulated T cell development and homeostasis. Development of CD8(+) T cells and NKT cells, maintenance of peripheral Foxp3-expressing regulatory T cells, and survival of CD4(+) T cells all depended on TGF-beta signaling. Both T helper 1 (Th1) differentiation and survival of activated CD4(+) T cells required T-bet, the TGF-beta-regulated transcription factor, which controlled CD122 expression and IL-15 signaling in Th1 cells. This study reveals pleiotropic functions of TGF-beta signaling in T cells that may ensure a diverse and self-tolerant T cell repertoire in vivo.
引用
收藏
页码:455 / 471
页数:17
相关论文
共 61 条
[1]   Commitment issues: linking positive selection signals and lineage diversification in the thymus [J].
Aliahmad, P ;
Kaye, J .
IMMUNOLOGICAL REVIEWS, 2006, 209 :253-273
[2]   Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[3]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[4]  
Cerwenka A, 1996, J IMMUNOL, V156, P459
[5]  
CERWENKA A, 1994, J IMMUNOL, V153, P4367
[6]   Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi [J].
Chen, ML ;
Pittet, MJ ;
Gorelik, L ;
Flavell, RA ;
Weissleder, R ;
von Boehmer, H ;
Khazaie, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) :419-424
[7]   Requirement for transforming growth factor β1 in controlling T cell apoptosis [J].
Chen, WJ ;
Jin, WW ;
Tian, HS ;
Sicurello, P ;
Frank, M ;
Orenstein, JM ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :439-453
[8]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[9]   Conditional inactivation of the TGF-β type II receptor using Cre:Lox [J].
Chytil, A ;
Magnuson, MA ;
Wright, CVE ;
Moses, HL .
GENESIS, 2002, 32 (02) :73-75
[10]  
DANG H, 1995, J IMMUNOL, V155, P3205